Skip to main navigation Skip to search Skip to main content

Internal BhamBRC: Validating whether CMV status is associated with toxicity and survival in patients who have received anti-cancer treatment with an immune checkpoint inhibitor

Project Details

Short titleInternal BhamBRC: Validating whether CMV status is associated with toxicity and survival in patients who have received anti-cancer treatment with an immune checkpoint inhibitor
StatusActive
Effective start/end date1/04/26 → 31/03/27

Funding

  • NIHR